A Review of Advances in Radiotherapy in the Setting of Esophageal Cancers
Surgical Oncology Clinics of North America · 2023
DOI: 10.1016/j.soc.2023.03.004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Surgical Oncology Clinics of North America, 2023. Verfasst von Joshua Cinicola und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Radiotherapy, Intensity-Modulated, Proton Therapy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 119 Literaturangaben. Gefördert von: NCI NIH HHS, NCI, Merck.
Abstract (Originalsprache)
Esophageal cancer is the eighth most common cancer worldwide and is the sixth most common cause of cancer-related mortality. The paradigm has shifted to include a multimodality approach with surgery, chemotherapy, targeted therapy (including immunotherapy), and radiation therapy. Advances in radiotherapy through techniques such as intensity modulated radiotherapy and proton beam therapy have allowed for the more dose homogeneity and improved organ sparing. In addition, recent studies of targeted therapies and predictive approaches in patients with locally advanced disease provide clinicians with new approaches to modify multimodality treatment to improve clinical outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA.
- Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson School of Medicine, Rutgers University, New Brunswick, NJ, USA.
- Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA, USA.
- New York Langone Perlmutter Cancer Center, New York, NY, USA.
- Department of Radiation Oncology, Rutgers Cancer Institute of New Jersey, Rutgers Robert Wood Johnson School of Medicine, Rutgers University, New Brunswick, NJ, USA. Electronic address: jabbousk@cinj.rutgers.edu.
Förderung
- NCI NIH HHS
- NCI
- Merck
- National Institutes of Health
Zitieren
APA
Cinicola, J., Mamidanna, S., Yegya-Raman, N., Spencer, K., Deek, M. P., & Jabbour, S. K. (2023). A Review of Advances in Radiotherapy in the Setting of Esophageal Cancers. Surgical Oncology Clinics of North America. https://doi.org/10.1016/j.soc.2023.03.004
Vancouver
Cinicola J, Mamidanna S, Yegya-Raman N, Spencer K, Deek MP, Jabbour SK. A Review of Advances in Radiotherapy in the Setting of Esophageal Cancers. Surgical Oncology Clinics of North America. 2023. doi:10.1016/j.soc.2023.03.004
BibTeX
@article{Cinicola2023,
author = {Cinicola, Joshua and Mamidanna, Swati and Yegya-Raman, Nikhil and Spencer, Kristen and Deek, Matthew P and Jabbour, Salma K},
title = {A Review of Advances in Radiotherapy in the Setting of Esophageal Cancers},
journal = {Surgical Oncology Clinics of North America},
year = {2023},
doi = {10.1016/j.soc.2023.03.004}
}
EUVIMED